FDA Media Briefing: Janssen COVID-19 Vaccine

WHAT:            A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine. This media briefing will be live streamed over the FDA’s YouTube page. WHO: Peter..

Read more